Sustanon 325

·        Form: Injectable solution

·        Presentation: 10 mL multi-dose vial

·        Active Ingredients (per 1 mL):

o   Testosterone Acetate: 30 mg

o   Testosterone Phenylpropionate: 50 mg

o   Testosterone Propionate: 50 mg

o   Testosterone Cypionate: 90 mg

o   Testosterone Decanoate: 105 mg

·        Total Testosterone Concentration: 325 mg/mL

·        Volume per Vial: 10 mL

·        Therapeutic Class: Androgenic anabolic steroid

·        Primary Use: Hormone replacement therapy (HRT) for testosterone deficiency, androgenic disorders, or as part of certain treatment protocols (e.g., delayed puberty, muscle wasting conditions).

·        Pharmacokinetics:

o   Combines fast-acting (Acetate, Propionate) and long-acting esters (Cypionate, Decanoate) for sustained release.

o   Peak effects vary by ester; half-lives range from days (Propionate) to weeks (Decanoate).

·        Administration: Deep intramuscular (IM) injection, typically every 2–4 weeks depending on clinical requirements.

·        Common Side Effects: Acne, fluid retention, gynecomastia, altered lipid profiles, virilization (in women), and potential hepatotoxicity with prolonged use.

·        Contraindications: Prostate cancer, severe cardiac/hepatic/renal disease, pregnancy, and hypersensitivity to components.

·        Storage: Store at controlled room temperature (15–30°C); protect from light.

·        Manufacturer/Supplier: Not specified in the provided label.